Dr. Michael L. Haas
Claim this profileReading Hospital
Studies Lung Cancer
Studies Prostate Adenocarcinoma
12 reported clinical trials
44 drugs studied
Area of expertise
1Lung Cancer
Stage II
Stage I
ALK positive
2Prostate Adenocarcinoma
Affiliated Hospitals
Clinical Trials Michael L. Haas is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
More about Michael L. Haas
Clinical Trial Related3 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Michael L. Haas has experience with
- Intensity-Modulated Radiation Therapy
- Cisplatin
- Atezolizumab
- Stereotactic Body Radiation Therapy
- Nivolumab
- Image Guided Radiation Therapy
Breakdown of trials Michael L. Haas has run
Lung Cancer
Prostate Adenocarcinoma
Squamous Cell Carcinoma
Throat Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael L. Haas specialize in?
Michael L. Haas focuses on Lung Cancer and Prostate Adenocarcinoma. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage I.
Is Michael L. Haas currently recruiting for clinical trials?
Yes, Michael L. Haas is currently recruiting for 7 clinical trials in West Reading Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Michael L. Haas has studied deeply?
Yes, Michael L. Haas has studied treatments such as Intensity-Modulated Radiation Therapy, Cisplatin, Atezolizumab.
What is the best way to schedule an appointment with Michael L. Haas?
Apply for one of the trials that Michael L. Haas is conducting.
What is the office address of Michael L. Haas?
The office of Michael L. Haas is located at: Reading Hospital, West Reading, Pennsylvania 19611 United States. This is the address for their practice at the Reading Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.